drugset / Trial / NCT01584726

Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma

NCT01584726

Unknown 400 enrolled Hamad Medical Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the use of magnesium sulfate nebulization in patient with moderate to severe asthma exacerbation in pediatric emergency.

Timeline

Start
2012-12
Primary completion
2015-03
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 800 mg Other

Indications